文献速递肝胆胰外科围术期管理与 ERAS

Extent I-III胸腹主动脉瘤无预防性脑脊液引流下开窗分支腔内修复的多中心研究

Multicenter Study to Evaluate Endovascular Repair of Extent I-III Thoracoabdominal Aneurysms Without Prophylactic Cerebrospinal Fluid Drainage.
PubMed 文献 · Ann Surg · 2022-08-04

该多中心研究纳入541例Extent I-III胸腹主动脉瘤患者,行开窗分支腔内修复(FB-EVAR)且未预防性行脑脊液引流(CSFD)。

要点

  • 无预防性CSFD的FB-EVAR治疗Extent I-III TAAA,永久性截瘫率仅2%。
  • SCI总发生率8%,Extent I-II较Extent III更常见(12% vs. 5%)。
  • 围术期持续低血压、主动脉覆盖总长度是SCI独立预测因素。

核心结论

  • FB-EVAR治疗Extent I-III TAAA时不行预防性CSFD,死亡率低且永久性截瘫率低(2%)。
  • SCI发生于8%的患者,其中73%经补救治疗后症状改善。

研究设计与样本

  • 多中心队列研究,纳入541例接受FB-EVAR治疗的Extent I-III TAAA患者,均未预防性行CSFD。
  • SCI分级为可行走(轻截瘫)或不可行走(截瘫)。

主要发现

  • Extent I-II患者SCI发生率12%,高于Extent III的5%(P=0.01)。
  • 补救治疗包括所有患者采用允许性高血压,22例(4%)行CSFD;73%患者症状改善。
  • 永久性截瘫12例(2%);重大引流相关并发症2例(0.4%)。
  • SCI独立预测因素:围术期持续低血压(OR 4.4,95%CI 1.7-11.1)、侧支网络通畅(OR 0.3,95%CI 0.1-0.6)、主动脉覆盖总长度(OR 1.05,95%CI 1.01-1.10)。

临床怎么用

  • 对于Extent I-III TAAA行FB-EVAR,可考虑不常规预防性放置CSFD,以降低引流相关并发症。
  • 术后需密切监测并积极处理围术期低血压,以降低SCI风险。
  • 发生SCI时可采用允许性高血压等补救治疗,必要时行CSFD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) of Extent I-III thoracoabdominal aortic aneurysms (TAAAs) without prophylactic cerebrospinal fluid drainage (CSFD). BACKGROUND: Prophylactic CSFD has been routinely used during endovascular TAAA repair, but concerns about major drain-related complications have led to revising this paradigm. METHODS: We reviewed a multicenter cohort of 541 patients treated for Extent I-III TAAAs by FB-EVAR without prophylactic CSFD. Spinal cord injury (SCI) was graded as ambulatory (paraparesis) or nonambulatory (paraplegia). Endpoints were any SCI, permanent paraplegia, response to rescue treatment, major drain-related complications, mortality, and patient survival. RESULTS: There were 22 Extent I, 240 Extent II and 279 Extent III TAAAs. Thirty-day mortality was 3%. SCI occurred in 45 patients (8%), paraparesis occurring in 23 (4%) and paraplegia in 22 patients (4%). SCI was more common in patients with Extent I-II compared with Extent III TAAAs (12% vs. 5%, P =0.01). Rescue treatment included permissive hypertension in all patients, with CSFD in 22 (4%). Symptom improvement was noted in 73%. Twelve patients (2%) had permanent paraplegia. Two patients (0.4%) had major drain-related complications. Independent predictors for SCI by multivariate logistic regression were sustained perioperative hypotension [odds ratio (OR): 4.4, 95% confidence interval (95% CI): 1.7-11.1], patent collateral network (OR: 0.3, 95% CI: 0.1-0.6), and total length of aortic coverage (OR: 1.05, 95% CI: 1.01-1.10). Patient survival at 3 years was 72%±3%. CONCLUSION: FB-EVAR of Extent I-III TAAAs without CSFD has low mortality and low rates of permanent paraplegia (2%). SCI occurred in 8% of patients, and rescue treatment improved symptoms in 73% of them.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Marcondes GB, Cirillo-Penn NC, Tenorio ER, et al. Multicenter Study to Evaluate Endovascular Repair of Extent I-III Thoracoabdominal Aneurysms Without Prophylactic Cerebrospinal Fluid Drainage. Ann Surg. 2022. PMID: 35925761. doi:10.1097/SLA.0000000000005653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。